Who is sponsoring NCT01719237?

NCT01719237 is sponsored by University of New Mexico.

What drugs are being tested in NCT01719237?

Interventions: Ropivacine and Chloroprocaine mixture, Ropivacaine only.

What is the status of NCT01719237?

NCT01719237 is currently COMPLETED.

Last reviewed 2023-05-23 · How we verify

Double Blinded Randomized Control Trial Comparing the Onset and Duration of Ultrasound Guided Supraclavicular Nerve Blocks Using Ropivacaine Versus Ropivacaine-Chloroprocaine Mixture

NCT01719237 Phase 4 COMPLETED Results posted

A double blinded randomized controlled trial comparing the onset and duration of the Onset and Duration of Ultrasound Guided Supraclavicular Nerve Blocks Using a long acting local anesthestic (Ropivacaine) with a mixture of a long and short acting local anesthestic (Ropivacaine-Chloroprocaine Mixture).

Details

Lead sponsor	University of New Mexico
Phase	Phase 4
Status	COMPLETED
Enrolment	60
Start date	2009-08
Completion	2010-11

Conditions

Pain

Interventions

Ropivacine and Chloroprocaine mixture
Ropivacaine only

Primary outcomes

Onset of Surgical Anesthesia — 45 minutes
Onset of surgical anesthesia is defined as the time after injection of local anesthetic to the time where no sensation of pinprick in the ulnar, median, radial and musculocutaneous nerves

Countries

United States